Pharmacotherapeutic Impact on Nonalcoholic Steatohepatitis Histology: A Systematic Review and Network Meta-analysis

吡格列酮 医学 硼胆酸 内科学 相对风险 胃肠病学 随机对照试验 2型糖尿病 糖尿病 置信区间 内分泌学 受体 兴奋剂
作者
Alexander J. Kovalic
出处
期刊:Journal of clinical and experimental hepatology [Elsevier BV]
卷期号:12 (4): 1057-1068 被引量:6
标识
DOI:10.1016/j.jceh.2022.01.011
摘要

Due to lack of targeted treatment options and inconsistent utilization of histologic endpoints among clinical trials, identifying efficacious pharmacotherapies for nonalcoholic steatohepatitis [NASH] has proven challenging.A thorough systematic review and frequentist random-effects network meta-analysis was performed across all randomized clinical trials reporting a pharmacotherapeutic intervention on biopsy-proven NASH. Primary outcomes were based on the most current, up-to-date recommended histologic endpoints.A total of 40 RCTs were identified including 6593 total patients. The most effective and statistically significant treatment interventions for minimum two-point improvement in NAFLD Activity Score were aldafermin 1 mg [RR 7.69, 95% CI 2.00; 29.57], vitamin E 800 IU in combination with pioglitazone 45 mg [RR 3.38, 95% CI 1.88; 6.07], pioglitazone 45 mg [RR 3.29, 95% CI 1.74; 6.22], vitamin E 800 IU [RR 2.06, 95% CI 1.33; 3.18], resmetirom 80 mg [RR 1.74, 95% CI 1.03; 2.94], obeticholic acid 25 mg [RR 1.63, 95% CI 1.32; 2.01], and obeticholic acid 10 mg [RR 1.31, 95% CI 1.02; 1.67]). The most robust pharmacotherapies for NASH resolution without worsening fibrosis were found to be aldafermin 1 mg [RR 5.77, 95% CI 1.48; 22.51], pioglitazone 45 mg [RR 2.65, 95% CI 1.43; 4.91], vitamin E 800 IU in combination with pioglitazone 45 mg [RR 2.64, 95% CI 1.36; 5.12], pioglitazone 30 mg [RR 2.46, 95% CI 1.56; 3.88], vitamin E 800 IU [RR 1.90, 95% CI 1.20; 3.00], and obeticholic acid 25 mg [RR 1.52, 95% CI 1.03; 2.23]). Obeticholic acid had a significant improvement on fibrosis. Multiple interventions were found to improve individual histologic scores across secondary outcome analyses and are detailed below.This novel systematic review and network meta-analysis represents the most comprehensive investigation to date regarding the pharmacotherapeutic options for biopsy-proven NASH using current recommended histologic endpoints.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
zebrafish完成签到 ,获得积分10
刚刚
美丽的盼夏完成签到,获得积分20
1秒前
1秒前
王新涛发布了新的文献求助10
1秒前
1秒前
molihuakai的应助被jasmine970000采纳,获得10
1秒前
GSW完成签到,获得积分10
2秒前
汉堡包的应助被山水采纳,获得10
2秒前
简单的草莓完成签到 ,获得积分10
2秒前
2秒前
少吃一口完成签到,获得积分10
2秒前
faker完成签到,获得积分10
2秒前
所所的应助被支摇伽采纳,获得10
3秒前
3秒前
3秒前
无花果的应助被淡淡觅波采纳,获得10
3秒前
田様的应助被月亮采纳,获得10
3秒前
神奇蜥蜴完成签到,获得积分10
3秒前
zzZ5发布了新的文献求助30
4秒前
4秒前
hafa发布了新的文献求助10
4秒前
张淘发布了新的文献求助10
4秒前
我是谁的应助被youtime采纳,获得30
5秒前
5秒前
Owen的应助被Taylor_Zhou采纳,获得10
5秒前
6秒前
迷路的梦凡完成签到,获得积分10
6秒前
薛定谔的猫完成签到,获得积分10
6秒前
八十光年发布了新的文献求助10
6秒前
faye发布了新的文献求助30
6秒前
6秒前
小潘同学完成签到,获得积分10
7秒前
聚乙二醇发布了新的文献求助10
7秒前
kousu完成签到,获得积分10
7秒前
7秒前
林林完成签到,获得积分10
8秒前
懵懂的狗完成签到,获得积分10
8秒前
abb完成签到 ,获得积分10
8秒前
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180713
求助须知:如何正确求助?哪些是违规求助? 9570752
关于积分的说明 21814119
捐赠科研通 7776960
什么是DOI,文献DOI怎么找? 3433298
关于科研通互助平台的介绍 2557579
邀请新用户注册赠送积分活动 2479287